View drug registration information details.


ItemsRegistration information
ID420
No420
Brand NameARICEPT EVESS 5 MG
IngredientsDONEPEZIL HYDROCHLORIDE 5 MG EQ.TO DONEPEZIL FREE BASE 4.56 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
StorageDO NOT STORE ABOVE 30'C
Shelf Life3 YEARS
Pack SizeBOX OF 28,30,56,60,98 OR 120 TABLETS
Dispensing CategoryPrescription only
ATC ClassificationN06DA02
Pharmaceutical ClassDEMENTIA
IndicationsSYMPTOMATIC TREATMENT OF MILD, MODERATELY SEVERE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE, VASCULAR DEMENTIA ( DEMENTIA ASSOCIATED WITH CEREBROVASCULAR DISEASE), DEMENTIA WITH LEWY BODIES( DLB).
ContraindicationsARICEPT IS CONTRAINDICATED IN PATIENTS WITH A KNOW HYPERSENSITIVITY TO DONEPEZIL HYDROCHLORIDE, PIPERIDINE DERIVATIVES, OR TO ANY EXCIPIENTS USED IN THE FORMULATION.
Side EffectsTHE MOST COMMON ADVERSE EVENTS ARE DIARRHOEA, MUSCLE CRAMPS,FATIGUE, NAUSEA, VOMITING AND INSOMNIA.
Unit Price-
EDL No
DescriptionWHITE, ROUND TABLETS DEBOSSED ARICEPT ON ONE SIDE AND 5 ON THE OTHER
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerBUSHU PHARMACEUTICALS LTD. MISATO FACTORY
CountryTHAILAND
Import Registration No1B 5/52( N)
Import Registration Date2009-11-27
ActivityCERTIFICATE RELEASED
Applied Date09-ARP-2022
FDD Registration No03 I 3781/12
FDD Registration Date2022-09-14
Expiry Date2025-09-13

Back to drug list